Location Washington, District of Columbia, United States Regions Washington DC Metro Area, Southern US Gender Male
LinkedIn View on LinkedIn
Robert Repella joined Vanda in October 2011. Prior to joining Vanda, Mr. Repella was Senior Vice President of Pharmaceutical Operations for the Americas Region at Cephalon. In this position he was responsible for all commercial operations in North and South America including brand marketing, sales, managed markets and new product planning. This
included oversight of all therapeutic categories (CNS, Oncology and Pain), partnerships agreements and the Mepha generics division.
Before joining Cephalon, Mr. Repella was Executive Vice President and General Manager of the Biopharma Business Unit for Wyeth Pharmaceuticals. In this position, he was responsible for the global portfolio of products across the immunology, oncology and hemophilia franchises. During his sixteen years at Wyeth, Mr. Repella served in various roles in both marketing and sales including Executive Vice President Pharmaceutical Sales, Marketing and Operations; Senior Vice President, Pharmaceutical Sales and Vice President, Global Business Manager, Enbrel®.
Earlier in his career, Mr. Repella held positions with Johnson & Johnson's McNeil Pharmaceutical Division, Merck & Co., Inc. and Eli Lilly & Co. Mr. Repella received his Bachelors Degree in Pharmacy from Rutgers University and a Masters in Business Administration from Temple University.
